Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 23%
Hold 31%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co is a promising company with a positive outlook due to its strong financial performance, diversified business mix, and solid growth prospects. The company's recent guidance revision increased the full-year adj. EBITDA guidance and operating cash flow projection, indicating improved financial health and potential for strong performance in the future. Additionally, the company's focus on reducing the number of facilities and creating a new operating group for JV hospitals and referral networks, as well as its strong M&A capacity, positions it well for continued growth. However, there are risks associated with the company, including potential reimbursement pressure and exposure to government investigations, which should be closely monitored. Overall, we believe that Acadia Healthcare Co is well-positioned to capture opportunities in the expanding behavioral healthcare industry and that its current valuation, based on an enterprise multiple of 8.5x its 2027 adjusted EBITDA estimate, represents a good buying opportunity for investors.

Bears say

Acadia Healthcare Co is expected to face several challenges such as market concentration risk due to a high percentage of its revenue coming from a small number of states, as well as reimbursement and government investigation risks. The company has implemented various preventive measures in response to the pandemic, but tight labor supply has impacted patient admission flow and could potentially hinder its expansion efforts. Additionally, while the pending Florida Deemed Provider Program (DPP) passage could provide a $22M benefit, there is uncertainty around its exact impact. Therefore, caution should be exercised in predicting future growth and profitability for Acadia Healthcare Co.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 23% recommend Buy, 31% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $30, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $30, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.